Breathe Well Live Well
|
Asthma Clinical Trials 2016 Review, Analysis By Global Market Research Store
Medgadget.com (blog) This report on Asthma also includes an review of trial numbers as well as their (Asthma) average enrollment in uppermost/top countries which are conducted worldwide. Asthma report also covers disease clinical trials by country (G7 & E7), sponsor type, … |
View full post on asthma – Google News
Medgadget.com (blog) |
Global Asthma Therapeutics Market 2015 Forecast 2020 by Market Research Store
Medgadget.com (blog) Asthma Therapeutics in Major Developed Markets to 2020 – Personalized Treatment for Severe Asthma to Drive Market Growth despite Patent Expirations””.The asthma therapeutics market is forecast to grow marginally over the forecast period across the top … |
View full post on asthma – Google News
|
Asthma Therapeutics Market 2015 in Major Developed by Market Research Store
Medgadget.com (blog) “Asthma Therapeutics in Major Developed Markets to 2020 – Personalized Treatment for Severe Asthma to Drive Market Growth despite Patent Expirations””.The asthma therapeutics market is forecast to grow marginally over the forecast period across the top … |
View full post on asthma – Google News
|
Asthma market to reach $23.1 billion due to targeted biologics
Drug Store News LONDON — The asthma treatment market value will grow from approximately $15.9 billion in 2013 across eight major countries (the United States, United Kingdom, France, Germany, Spain, Italy, Japan and Australia) to $23.1 billion by 2023, according to … |
View full post on asthma – Google News
|
Mylan settles suit over asthma, allergy drug
Drug Store News PITTSBURGH — Mylan has settled a patent infringement suit over a drug used to treat respiratory diseases, Mylan said. The generic drug maker said it resolved a patent litigation suit filed by Shionogi and Cima Labs over prednisolone sodium phosphate … |
View full post on asthma – Google News
|
Dr. Reddy's launches generic asthma, allergy, bronchospasm drug
Drug Store News HYDERABAD, India — Dr. Reddy's Labs has launched a generic drug for treating asthma and allergies and preventing bronchospasm during exercise, the company said Tuesday. The Indian company announced the launch of montelukast sodium oral … |
View full post on asthma – Google News
|
AllerMates adds asthma alert wristband to kid-friendly line
Drug Store News AllerMates said its collection now includes "Puffer" the asthma wristband. The wristband joins a lineup that includes other original characters that represent common allergies and health issues faced by kids today: peanut, nut, gluten/wheat, milk, egg … |
View full post on asthma – Google News
 YNN, Your News Now |
American College of Allergy, Asthma and Immunology dispels fall allergy myths
Drug Store News ARLINGTON HEIGHTS, Ill. — According to the American College of Allergy, Asthma and Immunology, 25 million adults and children across the country were diagnosed with rhinitis, or hay fever, within the last 12 months, which may lead many to believe … Asthma inhalers may cause thrush, bad breath Allergy season to make school day challenging for sufferers Child Wellness: Allergy-related asthma |
View full post on asthma – Google News
 MedPage Today |
FDA approves generic versions of asthma, allergy drug
Drug Store News SILVER SPRING, Md. — The Food and Drug Administration has approved several generic versions of a drug used to treat asthma and allergies, the agency said Friday. The FDA announced the approval of montelukast sodium, a drug indicated for controlling … First generic versions of Singulair receive FDA approval for treatment of … Generic Singulair Approved Teva asthma, allergy drug approved by FDA |
View full post on asthma – Google News
|
Mylan to challenge court decision over generic asthma, COPD drug
Drug Store News … in the US District Court for the District of Delaware when the latter sought to market a generic version of Sunovion's Xopenex (levalbuterol hydrochloride) inhalation solution, a drug for asthma and chronic obstructive pulmonary disease. Mylan to fight $18M patent infringement ruling |
View full post on asthma – Google News